Eledon Pharmaceuticals, Inc. · NASDAQ:ELDN
Eledon Pharmaceuticals, Inc. shareholders
As of Sep 30, 2026, 148 institutions reported holding Eledon Pharmaceuticals, Inc., 53.9% of its shares. Largest: BlackRock, Bvf Inc and Vanguard. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Eledon Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| BlackRock | 6.64M | 7.9% | +1.52M | Nov 13, 2026 |
| Bvf Inc | 6.29M | 7.5% | no change | Nov 16, 2026 |
| Vanguard | 4.57M | 5.4% | +67,171 | Nov 13, 2026 |
| Defilade Capital Management, L.P. | 3.53M | 4.2% | no change | Nov 16, 2026 |
| Goldman Sachs | 2.56M | 3.0% | +50,977 | Nov 16, 2026 |
| Geode Capital | 1.98M | 2.3% | +24,376 | Nov 6, 2026 |
| Ensign Peak Advisors, Inc | 1.76M | 2.1% | −345K | Nov 12, 2026 |
| Catalio Capital Management, LP | 1.64M | 1.9% | −57,957 | Nov 16, 2026 |
| State Street | 1.61M | 1.9% | −7,071 | Nov 12, 2026 |
| Sphera Funds Management LTD. | 1.39M | 1.6% | +201K | Nov 16, 2026 |